UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling

Nature neuroscience, 2009-09, Vol.12 (9), p.1152-1158

2009

Volltextzugriff (PDF)

Targeting the endocannabinoid system in the treatment of fragile X syndrome

Nature medicine, 2013-05, Vol.19 (5), p.603-607

2013

Volltextzugriff (PDF)

Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids

Philosophical transactions of the Royal Society of London. Series B. Biological sciences, 2012-12, Vol.367 (1607), p.3254-3263

2012

Volltextzugriff (PDF)

Differential Role of Anandamide and 2-Arachidonoylglycerol in Memory and Anxiety-like Responses

Biological psychiatry (1969), 2011-09, Vol.70 (5), p.479-486

2011

Volltextzugriff (PDF)

Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure

The Journal of clinical investigation, 2013-07, Vol.123 (7), p.2816-2831

2013

Volltextzugriff (PDF)

The cannabis paradox: when age matters

Nature medicine, 2017-06, Vol.23 (6), p.661-662

2017

Volltextzugriff (PDF)

Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation

Proceedings of the National Academy of Sciences - PNAS, 2016-08, Vol.113 (35), p.9904-9909

2016

Volltextzugriff (PDF)

Auricular transcutaneous vagus nerve stimulation improves memory persistence in naïve mice and in an intellectual disability mouse model

Brain stimulation, 2020-03, Vol.13 (2), p.494-498

2020

Volltextzugriff (PDF)

Monoacylglycerol lipase blockade impairs fine motor coordination and triggers cerebellar neuroinflammation through cyclooxygenase-2

Brain, behavior, and immunity, 2019-10, Vol.81, p.399-409

2019

Volltextzugriff (PDF)

Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol

Neuropsychopharmacology (New York, N.Y.), 2018-04, Vol.43 (5), p.1021-1031

2018

Volltextzugriff (PDF)

Protein Kinase C-Gamma Knockout Mice Show Impaired Hippocampal Short-Term Memory While Preserved Long-Term Memory

Molecular neurobiology, 2021-02, Vol.58 (2), p.617-630

2021

Volltextzugriff (PDF)

Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome

Neurobiology of disease, 2019-05, Vol.125, p.92-106

2019

Volltextzugriff (PDF)

Serotonergic mechanisms involved in antidepressant-like responses evoked by GLT-1 blockade in rat infralimbic cortex

Neuropharmacology, 2018-09, Vol.139, p.41-51

2018

Volltextzugriff (PDF)

Auricular Transcutaneous Vagus Nerve Stimulation Acutely Modulates Brain Connectivity in Mice

Frontiers in cellular neuroscience, 2022-04, Vol.16, p.856855-856855

2022

Volltextzugriff (PDF)

New insights into the molecular pathophysiology of fragile X syndrome and therapeutic perspectives from the animal model

The international journal of biochemistry & cell biology, 2014-08, Vol.53, p.121-126

2014

Volltextzugriff (PDF)

Sex-dependent psychoneuroendocrine effects of THC and MDMA in an animal model of adolescent drug consumption

PloS one, 2013-11, Vol.8 (11), p.e78386

2013

Volltextzugriff (PDF)

Amyloid β-Peptide Causes the Permanent Activation of CaMKIIα through Its Oxidation

International journal of molecular sciences, 2022-12, Vol.23 (23), p.15169

2022

Volltextzugriff (PDF)

CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal

Biological psychiatry (1969), 2017-04, Vol.81 (7), p.625-634

2017

Volltextzugriff (PDF)

Advances in the field of cannabinoid-opioid cross-talk

Addiction biology, 2008-06, Vol.13 (2), p.213-224

2008

Volltextzugriff (PDF)

A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome

Clinical nutrition (Edinburgh, Scotland), 2020-02, Vol.39 (2), p.378-387

2020

Volltextzugriff (PDF)

Functional protection in J20/VLW mice: a model of non-demented with Alzheimer's disease neuropathology

Brain (London, England : 1878), 2022-04, Vol.145 (2), p.729-743

2022

Volltextzugriff (PDF)

Role of the endocannabinoid system in a mouse model of Fragile X undergoing neuropathic pain

European journal of pain, 2021-07, Vol.25 (6), p.1316-1328

2021

Volltextzugriff (PDF)

Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism

Neuropsychopharmacology (New York, N.Y.), 2023-01, Vol.48 (2), p.341-350

2023

Volltextzugriff (PDF)

Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model

Genes, 2016-08, Vol.7 (9), p.56-56

2016

Volltextzugriff (PDF)

Physiological Control of Nitric Oxide in Neuronal BACE1 Translation by Heme-Regulated eIF2α Kinase HRI Induces Synaptogenesis

Antioxidants & redox signaling, 2015-05, Vol.22 (15), p.1295-1307

2015

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(62)
Buchkapitel
(1)

Sprache

Englisch
(63)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(37)
Animals
(30)
Neurosciences
(22)
Mice
(20)
Neurosciences & Neurology
(20)
Male
(15)
Humans
(14)
Memory
(14)
Hippocampus
(9)
Mice, Knockout
(9)
Rats
(9)
Cannabinoides
(8)
Biochemistry & Molecular Biology
(7)
Brain - Metabolism
(7)
Cognitive Ability
(7)
Endocannabinoid System
(7)
Proteins
(7)
Receptor, Cannabinoid, Cb1 - Metabolism
(7)
Cognition
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling

Targeting the endocannabinoid system in the treatment of fragile X syndrome

Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids

Differential Role of Anandamide and 2-Arachidonoylglycerol in Memory and Anxiety-like Responses

Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure

The cannabis paradox: when age matters

Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation

Auricular transcutaneous vagus nerve stimulation improves memory persistence in naïve mice and in an intellectual disability mouse model

Monoacylglycerol lipase blockade impairs fine motor coordination and triggers cerebellar neuroinflammation through cyclooxygenase-2

Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol

Protein Kinase C-Gamma Knockout Mice Show Impaired Hippocampal Short-Term Memory While Preserved Long-Term Memory

Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome

Serotonergic mechanisms involved in antidepressant-like responses evoked by GLT-1 blockade in rat infralimbic cortex

Auricular Transcutaneous Vagus Nerve Stimulation Acutely Modulates Brain Connectivity in Mice

New insights into the molecular pathophysiology of fragile X syndrome and therapeutic perspectives from the animal model

Sex-dependent psychoneuroendocrine effects of THC and MDMA in an animal model of adolescent drug consumption

Amyloid β-Peptide Causes the Permanent Activation of CaMKIIα through Its Oxidation

CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal

Advances in the field of cannabinoid-opioid cross-talk

A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome

Functional protection in J20/VLW mice: a model of non-demented with Alzheimer's disease neuropathology

Role of the endocannabinoid system in a mouse model of Fragile X undergoing neuropathic pain

Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism

Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model

Physiological Control of Nitric Oxide in Neuronal BACE1 Translation by Heme-Regulated eIF2α Kinase HRI Induces Synaptogenesis

Aktive Filter

Suchergebnisse filtern